Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis

Elevated right ventricular afterload following continuous-flow left ventricular assist device (CF-LVAD) may contribute to late right heart failure (LRHF). PDE5i (phosphodiesterase-5 inhibitors) are used to treat pulmonary hypertension and right heart dysfunction after CF-LVAD, but their impact on ou...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation. Heart failure 2022-04, Vol.15 (4), p.e008613-e008613
Hauptverfasser:	Grandin, E. Wilson, Gulati, Gaurav, Nunez, Jose I., Kennedy, Kevin, Rame, J. Eduardo, Atluri, Pavan, Pagani, Francis D., Kirklin, James K., Kormos, Robert L., Teuteberg, Jeffrey, Kiernan, Michael S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Cyclic Nucleotide Phosphodiesterases, Type 5 Heart Failure Heart Ventricles Heart-Assist Devices - adverse effects Humans Phosphodiesterase 5 Inhibitors - adverse effects Registries Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!